EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data‐Driven Approach Using Rotterdam Study Data

Chau L B Ho iD, David Youens, Walter P Abhayaratna, Max K Bulsara, Jeff Hughes, Rachael Moorin, Sallie-Anne Pearson, David B Preen, Christopher M Reid, Rikje Ruiter, Christobel M Saunders, Bruno H Stricker und 4 weitere

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70164 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Chau L B Ho und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Australia. Hauptthemen laut MEDLINE: Antihypertensive Agents, Pharmacoepidemiology, Hypertension, Drug Prescriptions. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Administrative medicine dispensing data often omit prescribed duration, which is important for research on adherence or other pharmacoepidemiological topics. While the reverse waiting time distribution (rWTD) method has been widely used to estimate prescribed durations, its accuracy in real‐world dispensing data is unknown. We assessed the performance of the rWTD method against the actual prescribed duration recorded in the Rotterdam Study.

Methods

100 725 antihypertensive (AHT) prescriptions from 2018 to 2019 were extracted from the Rotterdam Study's medicine data. Data were constructed into five scenarios with increasing variability in the number of medicines included and variations in prescribed duration. The rWTD with 10 random index dates with or without adjustment for the quantity of dispensed medicine was conducted in all scenarios. Relative differences and limit of agreement ratio based on Bland–Altman analysis were used to examine agreement between estimated and actual prescribed durations. Results rWTD models without adjustment for the quantity of dispensed medicine performed well only in the most homogenous scenario. In scenarios with greater data variability, performance improved significantly when adjusted for the quantity of dispensed medicine. Relative difference decreased from ≥ 65% in models without covariates to ≤ 20% with covariates, and the limit of agreement ratio decreased from ≥ 36.8 in models without covariates to ≤ 5.3 with covariates. Stratification analysis by subclass of the AHT medicines provided similar results.

Conclusions

The study demonstrated that as data variability increased, the accuracy of the rWTD estimations decreased. However, the rWTD can produce good estimates (relative difference from 0% to 28%) of prescribed duration for AHT medicines, with the highest accuracy in the model adjusting for the quantity of dispensed medicine or stratification of the data with a relative difference less than 20% and the limit of agreement ratio less than 5.3 for the estimation at the 90th percentile of inter‐arrival density. Since this validation was limited to antihypertensive medicines, generalizing the finding to other chronic‐use medicines should be undertaken with caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsPharmacoepidemiologyHypertensionDrug PrescriptionsHumansFemaleAgedMaleNetherlandsTime FactorsMiddle AgedDatabases, FactualAged, 80 and over

Stichwörter der Autor:innen

hypertensionpharmacoepidemiologyprescription durationwaiting time distribution

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Australia.
  • Cardiovascular Epidemiology Research Centre, School of Population and Global Health, The University of Western Australia, Perth, Australia.
  • Canberra Health Services, ACT, Canberra, Australia.
  • School of Medicine and Psychology, Australian National University, Canberra, Australia.
  • Institute for Health Research, The University of Notre Dame Australia, Fremantle, Australia.
  • Curtin Medical School, Curtin University, Perth, Australia.

ORCID-Profile: Chau L B Ho

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Ho, C. L. B., Youens, D., Abhayaratna, W. P., Bulsara, M. K., Hughes, J., Moorin, R., Pearson, S. A., Preen, D. B., Reid, C. M., Ruiter, R., Saunders, C. M., Stricker, B. H., Stubbs, J., van Rooij, F. J. A., Wright, C., & Ha, N. T. (2025). Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data‐Driven Approach Using Rotterdam Study Data. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70164

Vancouver

Ho CLB, Youens D, Abhayaratna WP, Bulsara MK, Hughes J, Moorin R, et al. Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data‐Driven Approach Using Rotterdam Study Data. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70164

BibTeX
@article{Ho2025,
  author = {Ho, Chau L B and Youens, David and Abhayaratna, Walter P and Bulsara, Max K and Hughes, Jeff and Moorin, Rachael and Pearson, Sallie-Anne and Preen, David B and Reid, Christopher M and Ruiter, Rikje and Saunders, Christobel M and Stricker, Bruno H and Stubbs, John and van Rooij, Frank J A and Wright, Cameron and Ha, Ninh Thi},
  title = {Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data‐Driven Approach Using Rotterdam Study Data},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70164}
}
Kostenlos starten →